Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
about
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerLymphatic Vessels, Inflammation, and Immunity in Skin CancerLymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-AnalysisInhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertensionDeciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast CancerProstaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblastsProstaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathwayInflammatory lymphangiogenesis in postpartum breast tissue remodelingEffect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells.Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNACyclooxygenase-1 and -2: molecular targets for cervical neoplasia.Interleukin-1β expression is required for lysophosphatidic Acid-induced lymphangiogenesis in human umbilical vein endothelial cellsCSNK1E/CTNNB1 are synthetic lethal to TP53 in colorectal cancer and are markers for prognosisScreening and identification of dietary oils and unsaturated fatty acids in inhibiting inflammatory prostaglandin E2 signaling in fat stromal cells.Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implicationsCyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancerExpression of COX-2 and HER-2 in colorectal cancer and their correlation.The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumorsIntegrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.PC4 induces lymphangiogenesis dependent VEGF-C/VEGF-D/VEGFR-3 axis activation in lung adenocarcinoma.Tumour angiogenesis, vascular biology and enhanced drug delivery.Myeloid cells and lymphangiogenesis.The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancerCyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.Potential therapeutic strategies for lymphatic metastasis.WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.Leptin promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-27b in human chondrosarcoma cells.CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells.Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells.MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2.Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma
P2860
Q24651871-33ADD121-51E9-4604-93BF-B18EEF6AA673Q26778332-CB207810-E81A-46CD-ADE3-B9A2E487E7D3Q26797490-5E4ADBC2-38B1-4AA7-9226-ED840BA6A1BEQ27331781-013717AE-322F-4DD9-9680-221E721E09C9Q28072448-CEB4FF3D-D722-4368-A5A2-51EA3EED66EAQ28569432-6DFEF9A6-18CE-4E52-87D1-04AEDB631F8DQ30430640-495B1CCD-618A-47D2-8781-E68C3C0EB894Q30436782-754D73F1-8496-4882-B49E-918996C4C8C5Q33314445-25A7E8B8-3F9D-4860-888C-A66A3FDD71D7Q33555154-170DA6DE-0F58-4E01-AEA1-C8437BC04463Q33890819-0FC367ED-AF5F-4DCA-B3DF-C7838581801AQ34117518-DAB09A04-3DCF-4DCE-8644-F2AEFB8864B2Q34141566-111D471E-39F6-4794-86C9-96A9FE12C4D3Q34167898-38994834-E26E-49B3-B22A-80A4A1822344Q34305332-386C2C30-F19E-49EE-B805-D1854E1E1A42Q34340057-D316913D-6B17-453A-A7DF-DDD7BBF4B38CQ34346431-953F11D4-945B-40A2-824A-B5CE92707FE9Q34400103-E58CD144-F186-478D-B044-2801CAD01492Q34414026-13370400-7578-4136-A885-442CEB111D41Q34567287-78CCAD0D-2B2D-4F5F-967B-8B4D076FBA06Q34637939-9E72E463-8132-4594-8627-B7AB59A61CF4Q34733346-382EEC94-1940-4CC4-A133-3AE905D380B9Q35651481-EA3C8D1C-40FC-473D-AAFD-04FC13621BD4Q35722400-1A3F5F80-9975-4FCE-985B-890E539B7E3DQ35805617-3DFC484F-8802-4055-BB12-3DE2A2DC08F9Q35929801-EE0E8C78-9D04-4C53-A430-CCE9E6DC2C4FQ35931998-E02BE6E2-84F8-44E4-8010-074C86B9377EQ36009237-8CAB4C22-7910-4110-9C55-DD1663B55C17Q36339264-DBDC10D0-A341-43AD-93A5-95BD4C0099D3Q36367559-0CAE6E8A-3253-4C03-AA1E-08F0DD1BE694Q36609908-9051127A-0D0B-40C0-8EFB-21479E940C8EQ36611067-39741BE1-BBB3-49D2-8ABB-0830BA68BF93Q36735345-4A3B9F6F-B1FB-47C8-8257-C0D22F7E66C1Q36851512-85B8A7FE-315E-437A-82A4-2E1F4FBA8B07Q36962844-11AC9CD7-7C5C-420C-907C-A5A3ED236BC0Q37040086-645B3BA7-9E62-440A-A54B-6539C7A21855Q37392868-AD5883FD-5E0D-4A97-8EB1-CF65E95F9B0DQ37437576-0D22F9BF-49DF-47EE-84D8-5D6D6BE2F8A2Q37475323-8B3A3DE3-92F0-4214-A68B-D2D85299739DQ37687452-9255FB93-1D02-423F-BD48-074B4C0850AE
P2860
Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@ast
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@en
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@nl
type
label
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@ast
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@en
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@nl
prefLabel
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@ast
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@en
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@nl
P2093
P50
P921
P1433
P1476
Cyclooxygenase-2 induces EP1- ...... enesis in lung adenocarcinoma.
@en
P2093
Chang-Yao Hsieh
Cheng-Chi Chang
Jen-Liang Su
Jin-Yuan Shih
Lin-Hung Wei
Pan-Chyr Yang
P304
P356
10.1158/0008-5472.CAN-03-1301
P407
P577
2004-01-01T00:00:00Z